ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | The association between dual RAAS inhibition and risk of AKI and hyperkalemia in patients with DKD

The association between dual RAAS inhibition and risk of AKI and hyperkalemia in patients with DKD

Share

https://www.youtube.com/watch?v=Gczf-GYe1No copy

Access paper

The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease

Other e-seminars from this series

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

ERA Journal Club

Patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist

ERA Journal Club

Monoclonal gammopathy of unknown significance in kidney transplanted patients

ERA Journal Club

All-cause and immune checkpoint inhibitor-associated acute kidney injury in immune checkpoint inhibitors users

ERA Journal Club

Age and time-dependent increase in incident anti-glomerular basement membrane disease

ERA Journal Club

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease

ERA Journal Club

Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease

ERA Journal Club

Women’s representation in clinical trials of patients with chronic kidney disease

ERA Journal Club

Nonsteroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease

ERA Journal Club

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D

ERA Journal Club

Who killed Bruce Lee? The hyponatraemia hypothesis

ERA Journal Club

Social determinants of health and the transition from advanced chronic kidney disease to kidney failure

ERA Journal Club